ATR

AptarGroup, Inc. ATR

$132.61 -2.14 (-1.59%)

Extended · +1.94σ

+ Compare Open in Sniper

Mkt cap $8.4B

P/E 21.4

Day $130.71 – $136.65

52wk $110.95 – $146.91

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

Plain English

AptarGroup, Inc. is a healthcare company listed in the US.

ATR last traded at $132.61, down 1.6% on the day; that's in the middle part of its 52-week range ($110.95–$146.91). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Under the hood

On the latest daily bar, momentum sits mid-range (RSI 68), the trend is strong (ADX 27), and volume is about normal (1.1×). On the business side, revenue is growing 11% year over year and the business keeps about 7 cents of every sales dollar as free cash.

Latest-bar indicator readings behind the grade — display-only, they don't move the letter.

Momentum · RSI

0–100 · <30 oversold

Trend strength · ADX

>25 = strong trend

Volume vs avg

1.10×

1× = average

Stretch from avg

+1.9 ATR

− below · + above

Zone touches

tests of this zone

Suggested hold

5–60

bars (≈ days)

Fundamentals at a glance

Company fundamentals for context — display-only, they don't move the grade.

Revenue growth

+10.8%

year over year

Free-cash-flow margin

6.7%

cash kept per $ of sales

Debt / equity

0.54

lower = less leveraged

P/E ratio

21.4

price ÷ yearly profit

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $78.75 (fair range $79–$178); today's price sits 59% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Intrinsic (DCF)

$78.75

Fair-value range

$78.75 – $177.55

Margin of safety

-59%

Verdict

Overvalued

Accounting quality Weak

✓ Positive retained earnings

⚠ Debt exceeds cash
⚠ Quick ratio 0.89 (fragile)
⚠ Receivables growing faster than revenue
⚠ Inventory growing faster than revenue

Price implies ~18% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

ATR is a $8.4 billion company, priced at 21× last year's earnings.

Mkt cap $8.4B

P/E ttm 21.4

Fwd P/E —

Beta —

Day range $130.71 – $136.65

52w range $110.95 – $146.91

Avg vol —

RSI(2) 61.3

ROE —

Net mgn —

FCF mgn 6.7%

Debt/Eq 0.54

Div yld —

Sector Healthcare

Industry Medical Instruments & Supplies

Next earn —

52-week range · today's price

$110.95$146.91